{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:42:09Z","timestamp":1777477329487,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.exer.2018.11.011","type":"journal-article","created":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T11:56:23Z","timestamp":1542110183000},"page":"188-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["The presence and distribution of G protein-coupled receptor 35 (GPR35) in the human cornea \u2013 Evidences from in silico gene expression analysis and immunodetection"],"prefix":"10.1016","volume":"179","author":[{"given":"Anna","family":"Matysik-Wo\u017aniak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2258-4225","authenticated-orcid":false,"given":"Artur","family":"Wnorowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waldemar A.","family":"Turski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"J\u00f3\u017awiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anselm","family":"J\u00fcnemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Rejdak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2018.11.011_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2018.01.004","article-title":"Kynurenic Acid and Gpr35 Regulate Adipose Tissue Energy Homeostasis and Inflammation","volume":"27","author":"Agudelo","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.exer.2018.11.011_bib2","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0002-9394(14)74786-5","article-title":"Efficacy and safety of lodoxamide 0.1% vs cromolyn sodium 4% in patients with vernal keratoconjunctivitis","volume":"113","author":"Caldwell","year":"1992","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2018.11.011_bib3","first-page":"1","article-title":"Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis","volume":"6","author":"Castillo","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.exer.2018.11.011_bib4","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.neuropharm.2010.11.014","article-title":"G-protein coupled receptor 35 (GPR35) activation and inflammatory pain: studies on the antinociceptive effects of kynurenic acid and zaprinast","volume":"60","author":"Cosi","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.exer.2018.11.011_bib5","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/00003226-200007000-00025","article-title":"Immunohistochemical localization of vascular endothelial growth factor, transforming growth factor alpha, and transforming growth factor beta1 in human corneas with neovascularization","volume":"19","author":"Cursiefen","year":"2000","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2018.11.011_bib6","first-page":"239","article-title":"Safety and efficacy of lodoxamide in vernal keratoconjunctivitis","volume":"61","author":"Das","year":"2011","journal-title":"J. Pakistan Med. Assoc."},{"key":"10.1016\/j.exer.2018.11.011_bib7","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1167\/iovs.16-20880","article-title":"Identification of circulating fibrocytes and dendritic derivatives in corneal endothelium of patients with fuchs' dystrophy","volume":"58","author":"De Roo","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2018.11.011_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2015.00041","article-title":"G protein-coupled receptor 35\u202f: an emerging target in inflammatory and cardiovascular disease","volume":"6","author":"Divorty","year":"2015","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.exer.2018.11.011_bib40","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/ajh\/hpy073","article-title":"The orphan receptor GPR35 contributes to angiotensin II-induced hypertension and cardiac dysfunction in mice","volume":"33","author":"Divorty","year":"2018","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.exer.2018.11.011_bib10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1586\/eop.10.8","article-title":"Fuchs' corneal dystrophy","volume":"5","author":"Eghrari","year":"2011","journal-title":"Expet Rev. Ophthalmol."},{"key":"10.1016\/j.exer.2018.11.011_bib11","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.bbrc.2010.06.091","article-title":"Biochemical and biophysical research communications expression of functional GPR35 in human iNKT cells","volume":"398","author":"Fallarini","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.exer.2018.11.011_bib12","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1124\/pr.113.008052","article-title":"G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives","volume":"66","author":"Ferre","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.exer.2018.11.011_bib13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.molimm.2013.11.019","article-title":"The role of complement activation in the pathogenesis of Fuchs' dystrophy","volume":"58","author":"F\u00fcst","year":"2014","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.exer.2018.11.011_bib14","doi-asserted-by":"crossref","first-page":"420747","DOI":"10.1155\/2008\/420747","article-title":"Genevestigator v3: a reference expression database for the meta-analysis of transcriptomes","author":"Hruz","year":"2008","journal-title":"Adv Bioinformatics"},{"key":"10.1016\/j.exer.2018.11.011_bib15","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1039\/c7ib00005g","article-title":"Chemical genomic analysis of GPR35 signaling","volume":"9","author":"Hu","year":"2017","journal-title":"Integr. Biol."},{"key":"10.1016\/j.exer.2018.11.011_bib16","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1124\/jpet.112.198945","article-title":"Antagonists of GPR35 display high species ortholog selectivity and varying modes of action","volume":"343","author":"Jenkins","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.exer.2018.11.011_bib17","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.2353\/ajpath.2010.100279","article-title":"Evidence of oxidative stress in the pathogenesis of Fuchs endothelial corneal dystrophy","volume":"177","author":"Jurkunas","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exer.2018.11.011_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2011.00068","article-title":"GPR35 as a novel therapeutic target","volume":"2","author":"Mackenzie","year":"2011","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.exer.2018.11.011_bib19","series-title":"Proc. 8th Int. Symp. CORNEA","first-page":"206","article-title":"Tryptophan, kynurenine and kynurenic acid in human tear fluid","author":"Matysik-Wo\u017aniak","year":"2016"},{"key":"10.1016\/j.exer.2018.11.011_bib21","first-page":"364","article-title":"The presence of kynurenine aminotransferases in the human cornea\u202f: evidence from bioinformatics analysis of gene expression and immunohistochemical staining","volume":"23","author":"Matysik-Wo\u017aniak","year":"2017","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2018.11.011_bib20","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.pharep.2017.02.020","article-title":"Effects of tryptophan, kynurenine and kynurenic acid exerted on human reconstructed corneal epithelium in vitro","volume":"69","author":"Matysik-Wo\u017aniak","year":"2017","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.exer.2018.11.011_bib22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.tips.2011.02.002","article-title":"Orthologue selectivity and ligand bias: translating the pharmacology of GPR35","volume":"32","author":"Milligan","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.exer.2018.11.011_bib23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00702-011-0763-x","article-title":"Kynurenic acid\u202f: a metabolite with multiple actions and multiple targets in brain and periphery","volume":"119","author":"Moroni","year":"2015","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.exer.2018.11.011_bib1","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1006\/geno.1998.5095","article-title":"Discovery of three novel G-protein-coupled receptor genes","volume":"47","author":"O'Dowd","year":"1998","journal-title":"Genomics"},{"key":"10.1016\/j.exer.2018.11.011_bib24","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/bph.14082","article-title":"GPR35 mediates lodoxamide-induced migration inhibitory response but not CXCL17-induced migration stimulatory response in THP-1 cells\u202f; is GPR35 a receptor for CXCL17\u202f?","volume":"175","author":"Park","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.exer.2018.11.011_bib25","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s10792-017-0588-1","article-title":"Efficacy and safety of 0.1% lodoxamide for the long-term treatment of superior limbic keratoconjunctivitis","volume":"38","author":"Rodriguez-Garcia","year":"2018","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.exer.2018.11.011_bib26","first-page":"1","article-title":"Fuchs endothelial corneal dystrophy: update on pathogenesis and future directions","volume":"0","author":"Sarnicola","year":"2018","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.exer.2018.11.011_bib27","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.exer.2018.11.011_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2015.00069","article-title":"The therapeutic potential of orphan GPCRs, GPR35 and GPR55","volume":"6","author":"Shore","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.exer.2018.11.011_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2017.00827","article-title":"The anti-allergic Cromones\u202f: past , present , and future","volume":"8","author":"Sinniah","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.exer.2018.11.011_bib30","doi-asserted-by":"crossref","first-page":"918","DOI":"10.15252\/msb.20167430","article-title":"Systematic protein\u2013protein interaction mapping for clinically relevant human GPCRs","volume":"13","author":"Sokolina","year":"2017","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.exer.2018.11.011_bib31","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.bbr.2016.01.002","article-title":"The positive allosteric modulator of alpha7 nicotinic acetylcholine receptors, 3-furan-2-yl-N-p-tolyl-acrylamide, enhances memory processes and stimulates ERK1\/2 phosphorylation in mice","volume":"302","author":"Targowska-Duda","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.exer.2018.11.011_bib32","doi-asserted-by":"crossref","first-page":"22021","DOI":"10.1074\/jbc.M603503200","article-title":"Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35","volume":"281","author":"Wang","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exer.2018.11.011_bib33","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/eye.2014.110","article-title":"The impact of new methods of investigation and treatment on the understanding of the pathology of scleral inflammation","volume":"28","author":"Watson","year":"2014","journal-title":"Eye"},{"key":"10.1016\/j.exer.2018.11.011_bib34","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.cellsig.2014.06.016","article-title":"Homo- and hetero-oligomerization of beta2-adrenergic receptor in receptor trafficking, signaling pathways and receptor pharmacology","volume":"26","author":"Wnorowski","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.exer.2018.11.011_bib35","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cellsig.2017.05.006","article-title":"Concurrent activation of beta2-adrenergic receptor and blockage of GPR55 disrupts pro-oncogenic signaling in glioma cells","volume":"36","author":"Wnorowski","year":"2017","journal-title":"Cell. Signal."},{"key":"10.1016\/j.exer.2018.11.011_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000314164","article-title":"G-protein-coupled receptor 35 is a target of the asthma drugs cromolyn disodium and nedocromil sodium","volume":"86","author":"Yang","year":"2010","journal-title":"Pharmacology"},{"key":"10.1016\/j.exer.2018.11.011_bib37","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1074\/jbc.M113.508382","article-title":"Crucial positively charged residues for ligand activation of the GPR35 receptor","volume":"289","author":"Zhao","year":"2014","journal-title":"J . Biol. Chem."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483518305992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483518305992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:28:28Z","timestamp":1762147708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483518305992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":38,"alternative-id":["S0014483518305992"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2018.11.011","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The presence and distribution of G protein-coupled receptor 35 (GPR35) in the human cornea \u2013 Evidences from in silico gene expression analysis and immunodetection","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2018.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}